{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35096118", "DateRevised": {"Year": "2022", "Month": "04", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "19"}], "Language": ["eng"], "ELocationID": ["7924171", "10.1155/2022/7924171"], "Journal": {"ISSN": "1741-427X", "JournalIssue": {"Volume": "2022", "PubDate": {"Year": "2022"}}, "Title": "Evidence-based complementary and alternative medicine : eCAM", "ISOAbbreviation": "Evid Based Complement Alternat Med"}, "ArticleTitle": "Phytochemical Analysis, <i>\u03b1</i>-Glucosidase and Amylase Inhibitory, and Molecular Docking Studies on <i>Persicaria hydropiper</i> L. Leaves Essential Oils.", "Pagination": {"StartPage": "7924171", "MedlinePgn": "7924171"}, "Abstract": {"AbstractText": ["Medicinal plants and essentials oils are well known for diverse biological activities including antidiabetic potential. This study was designed to isolate essential oils from the leaves of <i>Persicaria hydropiper</i> L. (<i>P. hydropiper</i>), perform its phytochemical analysis, and explore its in vitro antidiabetic effects.", "<i>P. hydropiper</i> leaves essential oils (Ph.Los) were extracted using a hydrodistillation apparatus and were subjected to phytochemical analysis using the gas chromatography mass spectrometry (GC-MS) technique. Ph.Lo was tested against two vital enzymes including <i>\u03b1</i>-glucosidase and <i>\u03b1</i>-amylase which are important targets in type-2 diabetes. The identified compounds were tested using <i>in silico</i> approaches for their binding affinities against the enzyme targets using MOE-Dock software.", "GC-MS analysis revealed the presence of 141 compounds among which dihydro-alpha-ionone, cis-geranylacetone, <i>\u03b1</i>-bulnesene, nerolidol, <i>\u03b2</i>-caryophyllene epoxide, and decahydronaphthalene were the most abundant compounds. Ph.Lo exhibited considerable inhibitory potential against <i>\u03b1</i>-glucosidase enzyme with 70% inhibition at 1000\u2009<i>\u03bc</i>g\u2009mL<sup>-1</sup> which was the highest tested concentration. The inhibitory activity of positive control acarbose was 77.30\u2009\u00b1\u20090.61% at the same tested concentration. Ph.Lo and acarbose exhibited IC<sub>50</sub> of 170 and 18\u2009\u00b5g\u2009mL<sup>-1</sup> correspondingly. Furthermore, dose-dependent inhibitions were observed for Ph.Lo against <i>\u03b1</i>-amylase enzyme with an IC<sub>50</sub> of 890\u2009<i>\u03bc</i>g\u2009mL<sup>-1</sup>. The top-ranked docking conformation was observed for <i>\u03b2</i>-caryophyllene epoxide with a docking score of -8.3182 against <i>\u03b1</i>-glucosidase, and it has established seven hydrogen bonds and one H-pi interaction at the active site residues (Phe 177, Glu 276, Arg 312, Asp 349, Gln 350, Asp 408, and Arg 439). Majority of the identified compounds fit well in the binding pocket of Tyr 62, Asp 197, Glu 233, Asp 300, His 305, and Ala 307 active residues of <i>\u03b1</i>-amylase. <i>\u03b2</i>-Caryophyllene epoxide was found to be the most active inhibitor with a docking score of -8.3050 and formed five hydrogen bonds at the active site residues of <i>\u03b1</i>-amylase. Asp 197, Glu 233, and Asp 300 active residues were observed to be making polar interactions with the ligand.", "The current study revealed that Ph.Lo is rich in bioactive metabolites which might contribute to its enzyme inhibitory potential. Inhibition of these enzymes is the key target in reducing postprandial hyperglycemia. However, further detailed in vivo studies are required for their biological and therapeutic activities."], "CopyrightInformation": "Copyright \u00a9 2022 Mater H. Mahnashi et al."}, "AuthorList": [{"Identifier": ["0000-0002-4837-3653"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran, Saudi Arabia."}], "LastName": "Mahnashi", "ForeName": "Mater H", "Initials": "MH"}, {"Identifier": ["0000-0001-8816-1842"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran, Saudi Arabia."}], "LastName": "Alqahtani", "ForeName": "Yahya S", "Initials": "YS"}, {"Identifier": ["0000-0002-6374-917X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran, Saudi Arabia."}], "LastName": "Alyami", "ForeName": "Bandar A", "Initials": "BA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran, Saudi Arabia."}], "LastName": "Alqarni", "ForeName": "Ali O", "Initials": "AO"}, {"Identifier": ["0000-0002-4299-2445"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Biological Sciences, University of Malakand, Chakdara, 18000 Dir (L), KP, Pakistan."}], "LastName": "Ayaz", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": ["0000-0002-1620-8610"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, UCS, Shankar, Abdul Wali Khan University, Mardan 23200, Pakistan."}], "LastName": "Ghufran", "ForeName": "Mehreen", "Initials": "M"}, {"Identifier": ["0000-0001-7907-0842"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Biological Sciences, University of Malakand, Chakdara, 18000 Dir (L), KP, Pakistan."}], "LastName": "Ullah", "ForeName": "Farhat", "Initials": "F"}, {"Identifier": ["0000-0002-0154-7863"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Biological Sciences, University of Malakand, Chakdara, 18000 Dir (L), KP, Pakistan."}], "LastName": "Sadiq", "ForeName": "Abdul", "Initials": "A"}, {"Identifier": ["0000-0001-6905-5366"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Swabi, Swabi, Pakistan."}], "LastName": "Ullah", "ForeName": "Ihsan", "Initials": "I"}, {"Identifier": ["0000-0001-6185-1907"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Institute of Health, Islamabad, Pakistan."}], "LastName": "Haq", "ForeName": "Ikram Ul", "Initials": "IU"}, {"Identifier": ["0000-0002-2163-0066"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia."}], "LastName": "Khalid", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": ["0000-0002-2361-086X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Applied Chemistry, School of Applied Natural Science, Adama Science and Technology University, P O Box 1888, Adama, Ethiopia."}], "LastName": "Murthy", "ForeName": "H C Ananda", "Initials": "HCA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Evid Based Complement Alternat Med", "NlmUniqueID": "101215021", "ISSNLinking": "1741-427X"}, "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ovais M., Ayaz M., Khalil A. T., et al. HPLC-DAD finger printing, antioxidant, cholinesterase, and \u03b1-glucosidase inhibitory potentials of a novel plant Olax nana. BMC Complementary and Alternative Medicine . 2018;18(1):1\u201313. doi: 10.1186/s12906-017-2057-9.", "ArticleIdList": ["10.1186/s12906-017-2057-9", "PMC5751879", "29295712"]}, {"Citation": "Mahnashi M. H., Alqahtani Y. S., Alqarni A. O., et al. Crude extract and isolated bioactive compounds from Notholirion thomsonianum (Royale) Stapf as multitargets antidiabetic agents: in-vitro and molecular docking approaches. BMC Complementary Medicine and Therapies . 2021;21(1):270\u2013313. doi: 10.1186/s12906-021-03443-7.", "ArticleIdList": ["10.1186/s12906-021-03443-7", "PMC8549260", "34706708"]}, {"Citation": "Arky R. Clinical Correlates of Metabolic Derangements of Diabetes Mellitus . Philadelphia, PA, USA: Complications of Diabetes Mellitus WB Saunders; 1982. pp. 16\u201320."}, {"Citation": "Booth G., Lipscombe L., Butalia S., et al. Pharmacologic management of type 2 diabetes: 2016 interim update. Canadian Journal of Diabetes . 2016;40(6):484\u2013486. doi: 10.1016/j.jcjd.2016.09.003.", "ArticleIdList": ["10.1016/j.jcjd.2016.09.003", "27912867"]}, {"Citation": "Ahmed F., Urooj A. Antihyperglycemic activity of Ficus glomerata stem bark in streptozotocin-induced diabetic rats. Global Journal of Pharmacology . 2008;2(3):41\u201345."}, {"Citation": "Kharroubi A. T., Darwish H. M. Diabetes mellitus: the epidemic of the century. World Journal of Diabetes . 2015;6(6):p. 850. doi: 10.4239/wjd.v6.i6.850.", "ArticleIdList": ["10.4239/wjd.v6.i6.850", "PMC4478580", "26131326"]}, {"Citation": "L\u00f6e H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care . 1993;16(1):329\u2013334.", "ArticleIdList": ["8422804"]}, {"Citation": "Kumar A., Ilavarasan R., Jayach T., et al. Anti-diabetic activity of Syzygium cumini and its isolated compound against streptozotocin-induced diabetic rats. Journal of Medicinal Plants Research . 2013;2(9):246\u2013249."}, {"Citation": "Whiting D. R., Guariguata L., Weil C., Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice . 2011;94(3):311\u2013321. doi: 10.1016/j.diabres.2011.10.029.", "ArticleIdList": ["10.1016/j.diabres.2011.10.029", "22079683"]}, {"Citation": "Cho N. H., Shaw J. E., Karuranga S., et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice . 2018;138:271\u2013281. doi: 10.1016/j.diabres.2018.02.023.", "ArticleIdList": ["10.1016/j.diabres.2018.02.023", "29496507"]}, {"Citation": "Gin H., Rigalleau V. Post-prandial hyperglycemia. post-prandial hyperglycemia and diabetes. Diabetes & Metabolism . 2000;26(4):265\u2013272.", "ArticleIdList": ["11011218"]}, {"Citation": "Nair S. S., Kavrekar V., Mishra A. In vitro studies on alpha amylase and alpha glucosidase inhibitory activities of selected plant extracts. European Journal of Experimental Biology . 2013;3(1):128\u2013132."}, {"Citation": "Ayaz M., Ullah F., Sadiq A., Kim M. O., Ali T. Editorial: natural products-based drugs: potential therapeutics against alzheimer\u2019s disease and other neurological disorders. Frontiers in Pharmacology . 2019;10:p. 1417. doi: 10.3389/fphar.2019.01417.", "ArticleIdList": ["10.3389/fphar.2019.01417", "PMC6889855", "31849668"]}, {"Citation": "Ullah I., Subhan F., Alam J., Shahid M., Ayaz M. Suppression of cisplatin-induced vomiting by cannabis sativa in pigeons: neurochemical evidences. Frontiers in Pharmacology . 2018;9:p. 231. doi: 10.3389/fphar.2018.00231.", "ArticleIdList": ["10.3389/fphar.2018.00231", "PMC5865282", "29615907"]}, {"Citation": "Saleem U., Akhtar R., Anwar F., et al. Neuroprotective potential of Malva neglecta is mediated via down-regulation of cholinesterase and modulation of oxidative stress markers. Metabolic Brain Disease . 2021;36(5):1\u201312. doi: 10.1007/s11011-021-00683-x.", "ArticleIdList": ["10.1007/s11011-021-00683-x", "33570733"]}, {"Citation": "Petrovska B. Historical review of medicinal plants\u2019 usage. Pharmacognosy Reviews . 2012;6(11):p. 1. doi: 10.4103/0973-7847.95849.", "ArticleIdList": ["10.4103/0973-7847.95849", "PMC3358962", "22654398"]}, {"Citation": "Khalil A. T., Ovais M., Iqbal J., et al. Seminars in Cancer Biology . Amsterdam, Netherlands: Elsevier; 2021. Microbes-mediated synthesis strategies of metal nanoparticles and their potential role in cancer therapeutics.", "ArticleIdList": ["10.1016/j.semcancer.2021.06.006", "34118405"]}, {"Citation": "Saleem U., Khalid S., Zaib S., et al. Phytochemical analysis and wound healing studies on ethnomedicinally important plant Malva neglecta Wallr. Journal of Ethnopharmacology . 2020;249 doi: 10.1016/j.jep.2019.112401.112401", "ArticleIdList": ["10.1016/j.jep.2019.112401", "31739103"]}, {"Citation": "Bailey C. J., Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care . 1989;12(8):553\u2013564. doi: 10.2337/diacare.12.8.553.", "ArticleIdList": ["10.2337/diacare.12.8.553", "2673695"]}, {"Citation": "Choudhury A., Maeda K., Murayama R., DiMagno E. Character of a wheat amylase inhibitor preparation and effects on fasting human pancreaticobiliary secretions and hormones. Gastroenterology . 1996;111(5):1313\u20131320. doi: 10.1053/gast.1996.v111.pm8898646.", "ArticleIdList": ["10.1053/gast.1996.v111.pm8898646", "8898646"]}, {"Citation": "Kumar V., Prakash O., Kumar S., Narwal S. \u03b1-glucosidase inhibitors from plants: a natural approach to treat diabetes. Pharmacognosy Reviews . 2011;5(9):p. 19. doi: 10.4103/0973-7847.79096.", "ArticleIdList": ["10.4103/0973-7847.79096", "PMC3210010", "22096315"]}, {"Citation": "Dirir A. M., Daou M., Yousef A. F., Yousef L. F. A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetes. Phytochemistry Reviews . 2021 doi: 10.1007/s11101-021-09773-1.", "ArticleIdList": ["10.1007/s11101-021-09773-1", "PMC8364835", "34421444"]}, {"Citation": "Ayaz M., Junaid M., Subhan F., et al. Heavy metals analysis, phytochemical, phytotoxic and anthelmintic investigations of crude methanolic extract, subsequent fractions and crude saponins from Polygonum hydropiper L. BMC Complementary and Alternative Medicine . 2014;14(1):p. 465. doi: 10.1186/1472-6882-14-465.", "ArticleIdList": ["10.1186/1472-6882-14-465", "PMC4289404", "25472835"]}, {"Citation": "Ayaz M., Ahmad I., Sadiq A., et al. Persicaria hydropiper (L.) Delarbre: a review on traditional uses, bioactive chemical constituents and pharmacological and toxicological activities. Journal of Ethnopharmacology . 2020;251 doi: 10.1016/j.jep.2019.112516.112516", "ArticleIdList": ["10.1016/j.jep.2019.112516", "31884037"]}, {"Citation": "Tong X., Li X., Ayaz M., et al. Neuroprotective studies on Polygonum hydropiper L. essential oils using transgenic animal models. Frontiers in Pharmacology . 2021;11 doi: 10.3389/fphar.2020.58006937.580069", "ArticleIdList": ["10.3389/fphar.2020.58006937", "PMC7873646", "33584260"]}, {"Citation": "Ayaz M., Junaid M., Ullah F., et al. Anti-alzheimer\u2019s studies on \u03b2-sitosterol isolated from Polygonum hydropiper L. Frontiers in Pharmacology . 2017;8:p. 697. doi: 10.3389/fphar.2017.00697.", "ArticleIdList": ["10.3389/fphar.2017.00697", "PMC5635809", "29056913"]}, {"Citation": "Ayaz M., Sadiq A., Wadood A., Junaid M., Ullah F., Zaman Khan N. Cytotoxicity and molecular docking studies on phytosterols isolated from Polygonum hydropiper L. Steroids . 2019;141:30\u201335. doi: 10.1016/j.steroids.2018.11.005.", "ArticleIdList": ["10.1016/j.steroids.2018.11.005", "30444979"]}, {"Citation": "Mahnashi M. H., Alqahtani Y. S., Alyami B. A., et al. Cytotoxicity, anti-angiogenic, anti-tumor and molecular docking studies on phytochemicals isolated from Polygonum hydropiper L. BMC Complementary Medicine and Therapies . 2021;21(1):1\u201314. doi: 10.1186/s12906-021-03411-1.", "ArticleIdList": ["10.1186/s12906-021-03411-1", "PMC8464109", "34560864"]}, {"Citation": "Ayaz M., Junaid M., Ullah F., et al. Chemical profiling, antimicrobial and insecticidal evaluations of Polygonum hydropiper L. BMC Complementary and Alternative Medicine . 2016;16(1):502\u2013514. doi: 10.1186/s12906-016-1491-4.", "ArticleIdList": ["10.1186/s12906-016-1491-4", "PMC5139080", "27919287"]}, {"Citation": "Ayaz M., Junaid M., Ullah F., et al. GC-MS analysis and gastroprotective evaluations of crude extracts, isolated saponins, and essential oil from Polygonum hydropiper L. Frontiers of Chemistry . 2017;5:p. 58. doi: 10.3389/fchem.2017.00058.", "ArticleIdList": ["10.3389/fchem.2017.00058", "PMC5539133", "28824906"]}, {"Citation": "Ayaz M., Junaid M., Ullah F., et al. Molecularly characterized solvent extracts and saponins from Polygonum hydropiper L. show high anti-angiogenic, anti-tumor, brine shrimp, and fibroblast NIH/3T3 cell line cytotoxicity. Frontiers in Pharmacology . 2016;7:p. 74. doi: 10.3389/fphar.2016.00074.", "ArticleIdList": ["10.3389/fphar.2016.00074", "PMC4814464", "27065865"]}, {"Citation": "Ayaz M., Junaid M., Ullah F., et al. Comparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L: a preliminary anti-alzheimer\u2019s study. Lipids in Health and Disease . 2015;14(1):1\u201312. doi: 10.1186/s12944-015-0145-8.", "ArticleIdList": ["10.1186/s12944-015-0145-8", "PMC4632677", "26530857"]}, {"Citation": "Stein S., Mirokhin D., Tchekhovskoi D., et al. The NIST Mass Spectral Search Program for the NIST/EPA/NIH Mass Spectra Library . Gaithersburg, MD, USA: Standard Reference Data Program of the National Institute of Standards and Technology Gaithersburg; 2002."}, {"Citation": "Adams RP. Identification of Essential Oil Components by Gas Chromatography/Mass Spectrometry . Vol. 456. Carol Stream, IL, USA: Allured Publishing Corporation; 2007."}, {"Citation": "McCue P., Kwon Y.-I., Shetty K. Anti-amylase, anti-glucosidase and anti-angiotensin I-converting enzyme potential of selected foods. Journal of Food Biochemistry . 2005;29(3):278\u2013294. doi: 10.1111/j.1745-4514.2005.00020.x.", "ArticleIdList": ["10.1111/j.1745-4514.2005.00020.x"]}, {"Citation": "Ghufran M., Rehman A. U., Shah M., Ayaz M., Ng H. L., Wadood A. In-silico design of peptide inhibitors of K-Ras target in cancer disease. Journal of Biomolecular Structure and Dynamics . 2020;38(18):5488\u20135499. doi: 10.1080/07391102.2019.1704880.", "ArticleIdList": ["10.1080/07391102.2019.1704880", "31838977"]}, {"Citation": "Ayaz M., Wadood A., Sadiq A., Ullah F., Anichkina O., Ghufran M. In-silico evaluations of the isolated phytosterols from Polygonum hydropiper L against BACE1 and MAO drug targets. Journal of Biomolecular Structure and Dynamics . 2021:1\u20139. doi: 10.1080/07391102.2021.1940286.", "ArticleIdList": ["10.1080/07391102.2021.1940286", "34157942"]}, {"Citation": "Liu M., Zhang W., Wei J., Lin X. Synthesis and \u03b1-glucosidase inhibitory mechanisms of bis(2,3-dibromo-4,5-dihydroxybenzyl) ether, a potential marine bromophenol \u03b1-glucosidase inhibitor. Marine Drugs . 2011;9(9):1554\u20131565. doi: 10.3390/md9091554.", "ArticleIdList": ["10.3390/md9091554", "PMC3225935", "22131958"]}, {"Citation": "Jabeen F., Oliferenko P. V., Oliferenko A. A., et al. Dual inhibition of the \u03b1-glucosidase and butyrylcholinesterase studied by molecular Field topology analysis. European Journal of Medicinal Chemistry . 2014;80:228\u2013242. doi: 10.1016/j.ejmech.2014.04.018.", "ArticleIdList": ["10.1016/j.ejmech.2014.04.018", "24780600"]}, {"Citation": "Hichri F., Omri A., Hossan A. S. M., Ben Jannet H. Alpha-glucosidase and amylase inhibitory effects of Eruca vesicaria subsp. longirostris essential oils: synthesis of new 1,2,4-triazole-thiol derivatives and 1,3,4-thiadiazole with potential inhibitory activity. Pharmaceutical Biology . 2019;57(1):564\u2013570. doi: 10.1080/13880209.2019.1642363.", "ArticleIdList": ["10.1080/13880209.2019.1642363", "PMC6720017", "31454271"]}, {"Citation": "Oboh G., Akinbola I. A., Ademosun A. O., et al. Essential oil from clove bud (Eugenia aromatica Kuntze) inhibit key enzymes relevant to the management of type-2 diabetes and some pro-oxidant induced lipid peroxidation in rats pancreas in vitro. Journal of Oleo Science . 2015;64(7):775\u2013782.", "ArticleIdList": ["25994557"]}, {"Citation": "Rahali N., Mehdi S., Younsi F., Boussaid M., Messaoud C. Antioxidant, \u03b1-amylase, and acetylcholinesterase inhibitory activities of Hertia cheirifolia essential oils: influence of plant organs and seasonal variation. International Journal of Food Properties . 2017;20(2):1637\u20131651. doi: 10.1080/10942912.2017.1352597.", "ArticleIdList": ["10.1080/10942912.2017.1352597"]}, {"Citation": "Majouli K., Besbes Hlila M., Hamdi A., Flamini G., Ben Jannet H., Kenani A. Antioxidant activity and \u03b1-glucosidase inhibition by essential oils from Hertia cheirifolia (L.) Industrial Crops and Products . 2016;82:23\u201328. doi: 10.1016/j.indcrop.2015.12.015.", "ArticleIdList": ["10.1016/j.indcrop.2015.12.015"]}, {"Citation": "Jaradat N., Al-Maharik N., Abdallah S., Shawahna R., Mousa A., Qtishat A. Nepeta curviflora essential oil: phytochemical composition, antioxidant, anti-proliferative and anti-migratory efficacy against cervical cancer cells, and \u03b1-glucosidase, \u03b1-amylase and porcine pancreatic lipase inhibitory activities. Industrial Crops and Products . 2020;158 doi: 10.1016/j.indcrop.2020.112946.112946", "ArticleIdList": ["10.1016/j.indcrop.2020.112946"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "10"}, {"Year": "2021", "Month": "12", "Day": "27"}, {"Year": "2022", "Month": "1", "Day": "31", "Hour": "5", "Minute": "57"}, {"Year": "2022", "Month": "2", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "1", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "1", "Day": "19"}], "PublicationStatus": "epublish", "ArticleIdList": ["35096118", "PMC8791729", "10.1155/2022/7924171"]}}], "PubmedBookArticle": []}